{
    "root": "034552a5-bc13-423a-951c-893e9f60c648",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Depakote",
    "value": "20250509",
    "ingredients": [
        {
            "name": "DIVALPROEX SODIUM",
            "code": "644VL95AO6"
        },
        {
            "name": "DIACETYLATED MONOGLYCERIDES",
            "code": "5Z17386USF"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "VANILLIN",
            "code": "CHI530446X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_18346"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "D&C RED NO. 30",
            "code": "2S42T2808B"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        }
    ],
    "indications": {
        "text": "depakote anti-epileptic indicated : treatment manic episodes associated bipolar disorder ( 1.1 ) monotherapy adjunctive therapy complex partial seizures simple complex absence seizures ; adjunctive therapy patients multiple seizure types include absence seizures ( 1.2 ) prophylaxis migraine headaches ( 1.3 )",
        "doid_entities": [
            {
                "text": "bipolar disorder (DOID:3312)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3312"
            },
            {
                "text": "migraine (DOID:6364)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6364"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "depakote tablets intended oral . depakote tablets swallowed whole crushed chewed . patients informed take depakote every day prescribed . dose missed taken soon possible , unless almost time next dose . dose skipped , patient double next dose .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "depakote tablets ( divalproex sodium delayed-release tablets ) supplied : 125 mg salmon pink-colored tablets : bottles 100 , tablets \u201c \u201d logo code nt \u2013 ndc 0074-6212-13 bottles 100 , tablets code nt \u2013 ndc 0074-7325-13 250 mg peach-colored tablets : bottles 100 , tablets \u201c \u201d logo code nr \u2013 ndc 0074-6214-13 bottles 100 , tablets code nr \u2013 ndc 0074-7326-13 500 mg lavender-colored tablets : bottles 100 , tablets \u201c \u201d logo code ns \u2013 ndc 0074-6215-13 bottles 100 , tablets code ns \u2013 ndc 0074-7327-13 recommended storage : store tablets 86\u00b0f ( 30\u00b0c ) .",
    "adverseReactions": "depakote contraindicated patients : \u2022 hepatic disease significant hepatic dysfunction [ ( 5.1 ) ] . \u2022 known mitochondrial disorders caused mutations mitochondrial dna polymerase \u03b3 ( polg ; e.g . , alpers-huttenlocher syndrome ) children two years age suspected polg-related disorder [ ( 5.1 ) ] . \u2022 known hypersensitivity divalproex sodium , sodium valproate , valproic acid . included multiorgan hypersensitivity , serious dermatologic , angioedema [ ( 5.12 , 5.13 , 5.14 ) ] . \u2022 known urea cycle disorders [ ( 5.6 ) ] . \u2022 treated prophylaxis migraine headaches pregnant women childbearing potential using effective contraception [ ( 5.2 , 5.3 , 5.4 ) ( 8.1 ) ] .",
    "indications_original": "Depakote is an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder ( 1.1 ) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1.2 ) Prophylaxis of migraine headaches ( 1.3 )",
    "contraindications_original": "Depakote tablets are intended for oral administration. Depakote tablets should be swallowed whole and should not be crushed or chewed. \n                  Patients should be informed to take Depakote every day as prescribed. If a dose is missed it should be taken as soon as possible, unless it is almost time for the next dose. If a dose is skipped, the patient should not double the next dose.",
    "warningsAndPrecautions_original": "Depakote tablets (divalproex sodium delayed-release tablets) are supplied as: \n                  125 mg salmon pink-colored tablets: \n                  \n                     Bottles of 100, tablets with the \u201ca\u201d logo and the code NT \u2013 NDC 0074-6212-13\n                     \n                     Bottles of 100, tablets with the code NT \u2013 NDC 0074-7325-13\n                  \n                  250 mg peach-colored tablets: \n                  \n                     Bottles of 100, tablets with the \u201ca\u201d logo and the code NR \u2013 NDC 0074-6214-13\n                     \n                     Bottles of 100, tablets with the code NR \u2013 NDC 0074-7326-13\n                  \n                  500 mg lavender-colored tablets: \n                  \n                     Bottles of 100, tablets with the \u201ca\u201d logo and the code NS \u2013 NDC 0074-6215-13\n                     \n                     Bottles of 100, tablets with the code NS \u2013 NDC 0074-7327-13\n                  \n                  Recommended Storage: Store tablets below 86\u00b0F (30\u00b0C).",
    "adverseReactions_original": "Depakote is contraindicated in patients:\n                  \u2022 with hepatic disease or significant hepatic dysfunction [see Warnings and Precautions \n                     (\n                     \n                        5.1\n                     \n                     )\n                     ]. \n                  \u2022 known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase \u03b3 (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder [see Warnings and Precautions \n                     (\n                     \n                        5.1\n                     \n                     )\n                     ]. \n                  \n                     \u2022 with known hypersensitivity to divalproex sodium, sodium valproate, or valproic acid.  Reactions have included multiorgan hypersensitivity, serious dermatologic reactions, and angioedema\u00a0[see Warnings and Precautions \n                        (\n                        \n                           5.12\n                        \n                        , \n                        \n                           5.13\n                        \n                        , \n                        \n                           5.14\n                        \n                        )\n                        ]. \n                  \n                  \u2022 with known urea cycle disorders [see Warnings and Precautions \n                     (\n                     \n                        5.6\n                     \n                     )\n                     ]. \n                  \u2022 being treated for prophylaxis of migraine headaches who are pregnant or in women of childbearing potential who are not using effective contraception [see Warnings and Precautions \n                     (\n                     \n                        5.2\n                     \n                     , \n                     \n                        5.3\n                     \n                     , \n                     \n                        5.4\n                     \n                     )\n                      and Use in Specific Populations \n                     (\n                     \n                        8.1\n                     \n                     )\n                     ].",
    "drug": [
        {
            "name": "Depakote"
        }
    ]
}